Speaker: Mislav Matejka, CFA, Head of Global Equity Strategy After a prolonged spell of weakness, at first driven by the inflation and bond yields spike last year, and then this year by macro recovery trade, certain Defensives are starting to trade a bit better of late. We think that Defensives could catch a more sustained bid if: 1. Bond yields could be in the process of peaking out, we reiterate the call from last month that one should go long duration. If the turn lower in bond yields is confirmed, on the Fed being done, a continued move down in inflation, but also on softer activity indicators, as seen in disappointing PMIs, then a range of Defensives should benefit. There is a clear link between bond yields and Utilities. Long bonds have lost half of their value over the past 3 years, as did Utilities relative, and that could be turning. Now, even if bond yields ramp up further, the trade might be on. Any break in yields above 5% will, in our view, be taken negatively by the market. In that scenario, Defensives might not behave as they did in August-September, when they underperformed against the backdrop of rising yields, but could be seen more as a traditional low beta part of the falling overall market. 2. Global output PMIs have been weakening for 5 months now, both manufacturing as well as services, and the risk is of a move into outright contraction. Money supply trends suggest that there could be more downside. 3. Earnings of Cyclical sectors are elevated vs Defensives, and are showing signs of a turn. In the latest reporting season, Cyclicals - Discretionary & Industrials had the most profit warnings, and Utilities the least. 4. Valuations of Defensives are not demanding anymore, having de-rated from outright expensive territory to fair value currently. Within Defensives, we have a preference for Utilities (OW), Telecoms (OW) and Staples (OW), and have recently upgraded Healthcare and Real Estate post the big spell of weakness. This podcast was recorded on 12 November 2023. This communication is provided for information purposes only. Institutional clients can view the related report at https://www.jpmm.com/research/content/GPS-4560156-0 for more information; please visit www.jpmm.com/research/disclosures for important disclosures. © 2023 JPMorgan Chase & Co. All rights reserved.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast